Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Distigmine (Atc Code According To Who: N07Aa03)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90981540

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient distigmine (ATC code acc ording to WHO: N07AA03). The contract is concluded within the framework of a so-called open house model, i.e. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not conducted and there is no (supply) exclusivity. It should be noted that the purchase quantity is unknown, as this depends on d

Mt Ref Id - 90981540

Deadline - Oct 31, 2026